GeneDx Holdings (WGSWW) EBIT Growth (1y) (2021 - 2026)
GeneDx Holdings (WGSWW) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -130.92% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.57% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.55% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 33.00% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -18.11% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.63% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 27.44% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 2.57% |
| 10 | GeneDx Holdings | - | - | 68.21 Mn | -1,162.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,162.82% |
| Dec 31, 2025 | -261.65% |
| Sep 30, 2025 | 58.21% |
| Jun 30, 2025 | 184.70% |
| Mar 31, 2025 | 66.68% |
| Dec 31, 2024 | 134.34% |
| Sep 30, 2024 | 81.89% |
| Jun 30, 2024 | 79.51% |
| Mar 31, 2024 | 77.37% |
| Dec 31, 2023 | 92.11% |
| Sep 30, 2023 | 52.69% |
| Jun 30, 2023 | 68.26% |
| Mar 31, 2023 | 32.41% |
| Dec 31, 2022 | -180.60% |
| Sep 30, 2022 | -2.89% |
| Jun 30, 2022 | -257.88% |
| Mar 31, 2022 | 54.59% |
| Dec 31, 2021 | 7.41% |
| Sep 30, 2021 | -57.57% |
| Jun 30, 2021 | -33.04% |